- Home
- IINN vs ATHA Comparison
IINN vs ATHA Comparison
Compare IINN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ATHA
- Stock Information
- Founded
- IINN 2018
- ATHA 2011
- Country
- IINN Israel
- ATHA United States
- Employees
- IINN N/A
- ATHA N/A
- Industry
- IINN Medical/Dental Instruments
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- IINN Health Care
- ATHA Health Care
- Exchange
- IINN Nasdaq
- ATHA Nasdaq
- Market Cap
- IINN 13.7M
- ATHA 10.6M
- IPO Year
- IINN 2021
- ATHA 2020
- Fundamental
- Price
- IINN $0.85
- ATHA $0.30
- Analyst Decision
- IINN Strong Buy
- ATHA Buy
- Analyst Count
- IINN 1
- ATHA 4
- Target Price
- IINN $2.00
- ATHA $11.25
- AVG Volume (30 Days)
- IINN 377.4K
- ATHA 1.3M
- Earning Date
- IINN 08-14-2025
- ATHA 07-31-2025
- Dividend Yield
- IINN N/A
- ATHA N/A
- EPS Growth
- IINN N/A
- ATHA N/A
- EPS
- IINN N/A
- ATHA N/A
- Revenue
- IINN N/A
- ATHA N/A
- Revenue This Year
- IINN N/A
- ATHA N/A
- Revenue Next Year
- IINN N/A
- ATHA N/A
- P/E Ratio
- IINN N/A
- ATHA N/A
- Revenue Growth
- IINN N/A
- ATHA N/A
- 52 Week Low
- IINN $0.40
- ATHA $0.22
- 52 Week High
- IINN $1.60
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- IINN 64.49
- ATHA 49.52
- Support Level
- IINN $0.81
- ATHA $0.29
- Resistance Level
- IINN $0.89
- ATHA $0.35
- Average True Range (ATR)
- IINN 0.06
- ATHA 0.03
- MACD
- IINN 0.01
- ATHA -0.00
- Stochastic Oscillator
- IINN 82.38
- ATHA 14.10
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.